Skip to content

Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00171691
Enrollment
450
Registered
2005-09-15
Start date
2004-10-31
Completion date
2006-06-30
Last updated
2012-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Knee osteoarthritis, Topical NSAID, Diclofenac sodium

Brief summary

This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.

Interventions

Sponsors

Novartis
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion criteria • Osteoarthritis of the knee Key

Exclusion criteria

* Other rheumatic disease, such as rheumatoid arthritis * Active gastrointestinal ulcer during the last year * Known allergy to analgesic drugs

Design outcomes

Primary

MeasureTime frame
Incidence of treatment-emergent adverse events
Number of laboratory values outside pre-determined ranges at Months 1, 3, 6, 9 and 12

Secondary

MeasureTime frame
Incidence of serious treatment-emergent adverse events
Number of patients who discontinued study medication due to a treatment-emergent adverse event
WOMAC pain, physical function and stiffness scores at Months 3, 6, 9 and 12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026